{"columns":[{"name":"Goal","type":"string"},{"name":"Target","type":"string"},{"name":"Indicator","type":"string"},{"name":"SeriesCode","type":"string"},{"name":"SeriesDescription","type":"string"},{"name":"GeoAreaCode","type":"string"},{"name":"GeoAreaName","type":"string"},{"name":"TimePeriod","type":"string"},{"name":"Value","type":"string"},{"name":"Time_Detail","type":"string"},{"name":"TimeCoverage","type":"string"},{"name":"UpperBound","type":"string"},{"name":"LowerBound","type":"string"},{"name":"BasePeriod","type":"string"},{"name":"Source","type":"string"},{"name":"GeoInfoUrl","type":"string"},{"name":"FootNote","type":"string"},{"name":"[Age]","type":"string"},{"name":"[Nature]","type":"string"},{"name":"[Reporting Type]","type":"string"},{"name":"[Units]","type":"string"}],"n_rows":321,"rows_kept":321,"cut":false,"text_format":"parquet-jsonl-2026-10-02","bounds":{"document_bytes":16777216,"package_text_limit_bytes":33554432,"package_text_slack_bytes":1024,"rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096,"vector_min":64,"vector_head_fixed":16,"vector_head_variable":64,"kv_value_chars":1048576,"nesting_max":64,"binary_text":true},"cells_cut":0,"cells_bad_utf8":0,"cells_raw":0,"cells_binary":0,"cells_binary_text":0,"cells_vector":0,"n_row_groups":1,"reader":"pyarrow 23.0.1, python 3.13","created_by":"DuckDB version v1.2.2 (build 7c039464e4)","schema":{"fields":[{"name":"Goal","type":"string","nullable":true,"metadata":null,"children":null},{"name":"Target","type":"string","nullable":true,"metadata":null,"children":null},{"name":"Indicator","type":"string","nullable":true,"metadata":null,"children":null},{"name":"SeriesCode","type":"string","nullable":true,"metadata":null,"children":null},{"name":"SeriesDescription","type":"string","nullable":true,"metadata":null,"children":null},{"name":"GeoAreaCode","type":"string","nullable":true,"metadata":null,"children":null},{"name":"GeoAreaName","type":"string","nullable":true,"metadata":null,"children":null},{"name":"TimePeriod","type":"string","nullable":true,"metadata":null,"children":null},{"name":"Value","type":"string","nullable":true,"metadata":null,"children":null},{"name":"Time_Detail","type":"string","nullable":true,"metadata":null,"children":null},{"name":"TimeCoverage","type":"string","nullable":true,"metadata":null,"children":null},{"name":"UpperBound","type":"string","nullable":true,"metadata":null,"children":null},{"name":"LowerBound","type":"string","nullable":true,"metadata":null,"children":null},{"name":"BasePeriod","type":"string","nullable":true,"metadata":null,"children":null},{"name":"Source","type":"string","nullable":true,"metadata":null,"children":null},{"name":"GeoInfoUrl","type":"string","nullable":true,"metadata":null,"children":null},{"name":"FootNote","type":"string","nullable":true,"metadata":null,"children":null},{"name":"[Age]","type":"string","nullable":true,"metadata":null,"children":null},{"name":"[Nature]","type":"string","nullable":true,"metadata":null,"children":null},{"name":"[Reporting Type]","type":"string","nullable":true,"metadata":null,"children":null},{"name":"[Units]","type":"string","nullable":true,"metadata":null,"children":null}],"parquet":"required group field_id=-1 duckdb_schema {\n  optional binary field_id=-1 Goal (String);\n  optional binary field_id=-1 Target (String);\n  optional binary field_id=-1 Indicator (String);\n  optional binary field_id=-1 SeriesCode (String);\n  optional binary field_id=-1 SeriesDescription (String);\n  optional binary field_id=-1 GeoAreaCode (String);\n  optional binary field_id=-1 GeoAreaName (String);\n  optional binary field_id=-1 TimePeriod (String);\n  optional binary field_id=-1 Value (String);\n  optional binary field_id=-1 Time_Detail (String);\n  optional binary field_id=-1 TimeCoverage (String);\n  optional binary field_id=-1 UpperBound (String);\n  optional binary field_id=-1 LowerBound (String);\n  optional binary field_id=-1 BasePeriod (String);\n  optional binary field_id=-1 Source (String);\n  optional binary field_id=-1 GeoInfoUrl (String);\n  optional binary field_id=-1 FootNote (String);\n  optional binary field_id=-1 [Age] (String);\n  optional binary field_id=-1 [Nature] (String);\n  optional binary field_id=-1 [Reporting Type] (String);\n  optional binary field_id=-1 [Units] (String);\n}\n"},"kv_metadata":[]}
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","1","World","2015","1.34","2015",null,"2.18","0.91",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","1","World","2018","0.91","2018",null,"1.02","0.8",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","1","World","2020","0.94","2020",null,"1.06","0.82",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","4","Afghanistan","2015","0.5","2015",null,"0.78","0.29",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","8","Albania","2015","1.29","2015",null,"1.91","0.83",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","9","Oceania","2015","2.21","2015",null,"2.85","1.66",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","9","Oceania","2018","1.86","2018",null,"2.19","1.59",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","9","Oceania","2020","1.29","2020",null,"1.52","1.09",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","12","Algeria","2015","0.22","2015",null,"0.34","0.12",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","12","Algeria","2018","0.06","2018",null,"0.08","0.05",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","12","Algeria","2020","0.08","2020",null,"0.1","0.06",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","20","Andorra","2015","0.08","2015",null,"1.65","0",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","24","Angola","2015","4.85","2015",null,"6.81","3.29",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","24","Angola","2018","3.84","2018",null,"4.83","3.05",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","24","Angola","2020","4.57","2020",null,"5.62","3.64",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","28","Antigua and Barbuda","2015","0.38","2015",null,"4.06","0.04",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","31","Azerbaijan","2015","0.27","2015",null,"0.5","0.13",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","32","Argentina","2015","0.01","2015",null,"0.01","0.01",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","36","Australia","2015","0.15","2015",null,"0.23","0.09",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","40","Austria","2015","0.32","2015",null,"0.62","0.15",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","44","Bahamas","2015","0.31","2015",null,"6.32","0.01",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","48","Bahrain","2015","0.18","2015",null,"0.24","0.13",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","50","Bangladesh","2015","1.38","2015",null,"1.91","0.97",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","51","Armenia","2015","0.25","2015",null,"2.05","0.04",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","52","Barbados","2015","0.34","2015",null,"4.81","0.02",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","53","Australia and New Zealand","2015","0.33","2015",null,"0.49","0.22",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","53","Australia and New Zealand","2018","0.17","2018",null,"0.2","0.14",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","53","Australia and New Zealand","2020","0.23","2020",null,"0.27","0.19",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","56","Belgium","2015","0.18","2015",null,"0.29","0.1",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","62","Central and Southern Asia","2015","0.85","2015",null,"1.15","0.62",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","62","Central and Southern Asia","2018","0.25","2018",null,"0.29","0.21",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","62","Central and Southern Asia","2020","0.31","2020",null,"0.36","0.26",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","64","Bhutan","2015","0.81","2015",null,"1.22","0.55",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","68","Bolivia (Plurinational State of)","2015","0.2","2015",null,"0.49","0.08",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","70","Bosnia and Herzegovina","2015","0.3","2015",null,"2.15","0.03",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","72","Botswana","2015","0.19","2015",null,"2.01","0.02",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","72","Botswana","2018","0.19","2018",null,"0.38","0.07",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","72","Botswana","2020","0.18","2020",null,"0.38","0.08",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","76","Brazil","2015","0.07","2015",null,"0.11","0.05",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","84","Belize","2015","1.49","2015",null,"2.21","0.98",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","90","Solomon Islands","2015","2.93","2015",null,"3.98","2.02",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","96","Brunei Darussalam","2015","0.34","2015",null,"0.56","0.2",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","100","Bulgaria","2015","0.31","2015",null,"0.5","0.19",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","104","Myanmar","2015","2.03","2015",null,"25.84","0.13",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","108","Burundi","2015","2.59","2015",null,"4.55","1.42",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","108","Burundi","2018","0.62","2018",null,"0.74","0.52",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","108","Burundi","2020","1.35","2020",null,"2.11","0.81",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","112","Belarus","2015","0.2","2015",null,"1.53","0.03",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","116","Cambodia","2015","0.56","2015",null,"0.79","0.37",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","120","Cameroon","2015","1.9","2015",null,"2.61","1.34",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","120","Cameroon","2018","1.72","2018",null,"2.03","1.46",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","120","Cameroon","2020","1.75","2020",null,"2.05","1.49",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","124","Canada","2015","1.03","2015",null,"1.42","0.72",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","132","Cabo Verde","2015","0.71","2015",null,"1.42","0.35",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","132","Cabo Verde","2018","0.2","2018",null,"0.3","0.13",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","132","Cabo Verde","2020","0.26","2020",null,"0.37","0.17",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","140","Central African Republic","2015","6.62","2015",null,"8.62","5.12",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","140","Central African Republic","2018","3.86","2018",null,"4.47","3.27",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","140","Central African Republic","2020","3.75","2020",null,"4.38","3.21",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","144","Sri Lanka","2015","0.64","2015",null,"0.97","0.41",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","148","Chad","2015","3.08","2015",null,"26.2","0.29",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","148","Chad","2018","12.6","2018",null,"14.72","10.6",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","148","Chad","2020","10.79","2020",null,"12.78","9.15",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","152","Chile","2015","0.28","2015",null,"0.57","0.11",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","156","China","2015","0.83","2015",null,"1.18","0.56",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","170","Colombia","2015","0.21","2015",null,"0.33","0.13",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","174","Comoros","2015","1.96","2015",null,"18.01","0.15",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","174","Comoros","2018","1.02","2018",null,"8.61","0.09",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","174","Comoros","2020","1.16","2020",null,"6.73","0.15",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","178","Congo","2015","4.11","2015",null,"6.57","2.53",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","178","Congo","2018","1.98","2018",null,"2.39","1.63",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","178","Congo","2020","2.56","2020",null,"3.31","1.94",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","180","Democratic Republic of the Congo","2015","1.43","2015",null,"2.01","0.98",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","180","Democratic Republic of the Congo","2018","1.64","2018",null,"1.91","1.39",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","180","Democratic Republic of the Congo","2020","3.28","2020",null,"4.2","2.55",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","184","Cook Islands","2015","0.22","2015",null,"4.98","0.01",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","188","Costa Rica","2015","0.17","2015",null,"1.73","0.02",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","191","Croatia","2015","0.11","2015",null,"0.17","0.07",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","192","Cuba","2015","0.12","2015",null,"0.25","0.05",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","196","Cyprus","2015","0.6","2015",null,"0.98","0.37",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","199","Least Developed Countries (LDCs)","2018","2.09","2018",null,"2.54","1.74",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","199","Least Developed Countries (LDCs)","2020","2.21","2020",null,"2.74","1.8",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","202","Sub-Saharan Africa","2015","3.23","2015",null,"4.97","2.22",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","202","Sub-Saharan Africa","2018","2.76","2018",null,"3.28","2.35",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","202","Sub-Saharan Africa","2020","2.66","2020",null,"3.23","2.21",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","203","Czechia","2015","0.39","2015",null,"0.63","0.23",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","204","Benin","2015","5.55","2015",null,"8.14","3.62",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","204","Benin","2018","2.51","2018",null,"3.04","2.04",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","204","Benin","2020","2.87","2020",null,"3.44","2.4",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","208","Denmark","2015","0.79","2015",null,"1.06","0.57",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","212","Dominica","2015","0.39","2015",null,"2.66","0.04",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","214","Dominican Republic","2015","0.34","2015",null,"3.33","0.03",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","218","Ecuador","2015","0.32","2015",null,"3.01","0.04",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","222","El Salvador","2015","0.57","2015",null,"6.59","0.05",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","226","Equatorial Guinea","2015","8.66","2015",null,"11.2","6.75",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","226","Equatorial Guinea","2018","7.32","2018",null,"8.49","6.32",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","226","Equatorial Guinea","2020","6.07","2020",null,"7.21","5.06",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","231","Ethiopia","2015","2.61","2015",null,"3.37","1.9",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","231","Ethiopia","2018","1.47","2018",null,"1.67","1.27",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","231","Ethiopia","2020","1.59","2020",null,"1.85","1.36",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","232","Eritrea","2015","0.74","2015",null,"1.05","0.49",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","232","Eritrea","2018","0.45","2018",null,"0.53","0.38",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","232","Eritrea","2020","1.02","2020",null,"1.71","0.59",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","233","Estonia","2015","0.36","2015",null,"2.81","0.06",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","242","Fiji","2015","0.34","2015",null,"0.52","0.21",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","246","Finland","2015","1.05","2015",null,"10.74","0.11",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","250","France","2015","0.01","2015",null,"0.01","0.01",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","262","Djibouti","2015","0.64","2015",null,"5.19","0.07",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","266","Gabon","2015","4.16","2015",null,"5.67","2.99",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","266","Gabon","2018","2.04","2018",null,"2.34","1.77",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","266","Gabon","2020","2.12","2020",null,"2.48","1.78",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","268","Georgia","2015","0.26","2015",null,"0.42","0.16",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","270","Gambia","2015","1.17","2015",null,"1.73","0.8",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","270","Gambia","2018","1.71","2018",null,"2.06","1.43",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","270","Gambia","2020","1.6","2020",null,"1.89","1.35",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","276","Germany","2015","0.24","2015",null,"0.37","0.15",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","288","Ghana","2015","3.61","2015",null,"5","2.5",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","288","Ghana","2018","2.09","2018",null,"2.45","1.76",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","288","Ghana","2020","2.13","2020",null,"2.56","1.75",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","296","Kiribati","2015","3.65","2015",null,"5.18","2.51",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","300","Greece","2015","0.37","2015",null,"0.52","0.25",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","308","Grenada","2015","0.47","2015",null,"4.35","0.06",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","320","Guatemala","2015","0.05","2015",null,"0.08","0.03",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","324","Guinea","2015","7.47","2015",null,"13.98","3.7",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","324","Guinea","2018","7.7","2018",null,"8.91","6.74",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","324","Guinea","2020","6.07","2020",null,"7.24","5.1",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","328","Guyana","2015","0.95","2015",null,"14.69","0.06",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","332","Haiti","2015","2.04","2015",null,"3.1","1.26",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","340","Honduras","2015","0.25","2015",null,"2.82","0.02",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","348","Hungary","2015","0.44","2015",null,"0.97","0.18",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","352","Iceland","2015","0.88","2015",null,"10.46","0.06",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","356","India","2015","0.51","2015",null,"0.65","0.38",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","360","Indonesia","2015","1.07","2015",null,"1.55","0.69",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","364","Iran (Islamic Republic of)","2015","0.02","2015",null,"0.03","0.01",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","368","Iraq","2015","0.06","2015",null,"0.08","0.04",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","372","Ireland","2015","0.01","2015",null,"0.02","0",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","376","Israel","2015","0.48","2015",null,"0.69","0.32",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","380","Italy","2015","0.61","2015",null,"0.93","0.39",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","384","Côte d'Ivoire","2015","3.04","2015",null,"4.39","2.01",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","384","Côte d'Ivoire","2018","2.94","2018",null,"3.37","2.56",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","384","Côte d'Ivoire","2020","3.44","2020",null,"4.06","2.9",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","388","Jamaica","2015","0.16","2015",null,"0.51","0.04",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","392","Japan","2015","1.95","2015",null,"2.53","1.5",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","398","Kazakhstan","2015","0.21","2015",null,"0.32","0.14",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","400","Jordan","2015","1.01","2015",null,"1.73","0.55",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","404","Kenya","2015","0.86","2015",null,"1.22","0.6",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","404","Kenya","2018","0.5","2018",null,"0.6","0.41",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","404","Kenya","2020","0.4","2020",null,"0.48","0.33",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","408","Democratic People's Republic of Korea","2015","0.53","2015",null,"6.89","0.04",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","410","Republic of Korea","2015","0.69","2015",null,"0.94","0.49",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","414","Kuwait","2015","0.11","2015",null,"1.97","0.01",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","417","Kyrgyzstan","2015","0.5","2015",null,"3.76","0.05",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","418","Lao People's Democratic Republic","2015","1.94","2015",null,"2.73","1.34",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","419","Latin America and the Caribbean","2015","0.2","2015",null,"0.69","0.1",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","419","Latin America and the Caribbean","2018","0.08","2018",null,"0.17","0.05",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","419","Latin America and the Caribbean","2020","0.09","2020",null,"0.16","0.06",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","422","Lebanon","2015","0.21","2015",null,"0.3","0.14",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","426","Lesotho","2015","1.64","2015",null,"17.27","0.16",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","426","Lesotho","2018","1.08","2018",null,"14.13","0.08",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","426","Lesotho","2020","1.22","2020",null,"8.88","0.14",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","428","Latvia","2015","0.51","2015",null,"4.68","0.06",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","430","Liberia","2015","7.75","2015",null,"10.44","5.56",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","430","Liberia","2018","4.01","2018",null,"4.94","3.22",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","430","Liberia","2020","4.66","2020",null,"5.69","3.78",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","432","Landlocked developing countries (LLDCs)","2018","0.48","2018",null,"0.74","0.37",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","432","Landlocked developing countries (LLDCs)","2020","0.55","2020",null,"0.87","0.42",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","434","Libya","2015","0.27","2015",null,"0.41","0.18",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","440","Lithuania","2015","0.19","2015",null,"0.3","0.11",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","442","Luxembourg","2015","0.24","2015",null,"4.06","0.02",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","450","Madagascar","2015","4.36","2015",null,"5.91","3.06",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","450","Madagascar","2018","1.3","2018",null,"1.49","1.12",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","450","Madagascar","2020","2.13","2020",null,"2.49","1.79",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","454","Malawi","2015","3.03","2015",null,"4.36","1.92",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","454","Malawi","2018","1.42","2018",null,"1.84","1.11",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","454","Malawi","2020","1.39","2020",null,"1.78","1.08",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","458","Malaysia","2015","0.17","2015",null,"0.27","0.11",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","462","Maldives","2015","0.19","2015",null,"2.36","0.01",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","466","Mali","2015","4.88","2015",null,"6.81","3.23",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","466","Mali","2018","4.55","2018",null,"5.18","3.95",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","466","Mali","2020","4.62","2020",null,"5.49","3.78",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","470","Malta","2015","0.39","2015",null,"3.14","0.05",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","478","Mauritania","2015","4.29","2015",null,"5.96","2.92",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","478","Mauritania","2018","3.87","2018",null,"4.59","3.24",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","478","Mauritania","2020","3.35","2020",null,"4.13","2.74",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","480","Mauritius","2015","0.61","2015",null,"7.19","0.07",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","480","Mauritius","2018","0.33","2018",null,"2.94","0.03",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","480","Mauritius","2020","0.41","2020",null,"2.93","0.06",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","484","Mexico","2015","0.04","2015",null,"0.06","0.03",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","492","Monaco","2015","0.2","2015",null,"2.94","0.01",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","496","Mongolia","2015","1.72","2015",null,"2.57","1.14",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","498","Republic of Moldova","2015","0.65","2015",null,"1.02","0.41",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","499","Montenegro","2015","0.65","2015",null,"4.4","0.1",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","504","Morocco","2015","0.45","2015",null,"0.63","0.31",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","508","Mozambique","2015","3.67","2015",null,"5.46","2.51",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","508","Mozambique","2018","2.41","2018",null,"2.84","2.03",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","508","Mozambique","2020","0.59","2020",null,"1.36","0.21",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","512","Oman","2015","0.44","2015",null,"0.71","0.26",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","513","Europe and Northern America","2015","0.3","2015",null,"0.55","0.2",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","513","Europe and Northern America","2018","0.16","2018",null,"0.21","0.13",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","513","Europe and Northern America","2020","0.21","2020",null,"0.28","0.17",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","516","Namibia","2015","0.66","2015",null,"0.91","0.46",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","516","Namibia","2018","0.21","2018",null,"0.26","0.18",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","516","Namibia","2020","0.36","2020",null,"0.43","0.3",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","520","Nauru","2015","2.11","2015",null,"3.05","1.4",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","524","Nepal","2015","0.31","2015",null,"0.43","0.2",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","528","Netherlands (Kingdom of the)","2015","0.04","2015",null,"0.05","0.03",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","548","Vanuatu","2015","8.48","2015",null,"10.98","6.45",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","554","New Zealand","2015","1.2","2015",null,"1.7","0.83",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","558","Nicaragua","2015","0.14","2015",null,"0.29","0.06",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","562","Niger","2015","6.01","2015",null,"9.44","3.77",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","562","Niger","2018","4.3","2018",null,"5.03","3.64",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","562","Niger","2020","3.44","2020",null,"4.5","2.63",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","566","Nigeria","2015","2.61","2015",null,"3.47","1.96",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","566","Nigeria","2018","4.12","2018",null,"4.66","3.63",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","566","Nigeria","2020","2.94","2020",null,"3.32","2.57",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","570","Niue","2015","0.24","2015",null,"5.39","0.01",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","578","Norway","2015","0.01","2015",null,"0.03","0",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","583","Micronesia (Federated States of)","2015","0.89","2015",null,"1.44","0.58",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","584","Marshall Islands","2015","1.56","2015",null,"2.41","0.99",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","585","Palau","2015","0.21","2015",null,"3.83","0.01",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","586","Pakistan","2015","2.75","2015",null,"3.67","2.02",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","591","Panama","2015","0.22","2015",null,"0.33","0.15",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","598","Papua New Guinea","2015","2.24","2015",null,"2.85","1.68",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","600","Paraguay","2015","0.65","2015",null,"8.94","0.05",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","604","Peru","2015","0.24","2015",null,"0.35","0.16",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","608","Philippines","2015","1.07","2015",null,"1.44","0.76",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","616","Poland","2015","0.04","2015",null,"0.06","0.02",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","620","Portugal","2015","0.1","2015",null,"0.17","0.05",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","624","Guinea-Bissau","2015","2.12","2015",null,"20.45","0.18",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","624","Guinea-Bissau","2018","2.39","2018",null,"18.66","0.25",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","624","Guinea-Bissau","2020","2.11","2020",null,"9.75","0.41",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","626","Timor-Leste","2015","0.87","2015",null,"1.56","0.45",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","634","Qatar","2015","0.2","2015",null,"0.34","0.11",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","642","Romania","2015","0.65","2015",null,"0.93","0.44",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","643","Russian Federation","2015","0.88","2015",null,"1.26","0.58",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","646","Rwanda","2015","1.74","2015",null,"3.3","0.86",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","646","Rwanda","2018","0.31","2018",null,"0.37","0.26",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","646","Rwanda","2020","0.49","2020",null,"0.6","0.41",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","659","Saint Kitts and Nevis","2015","0.38","2015",null,"3.06","0.04",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","662","Saint Lucia","2015","0.39","2015",null,"3.17","0.05",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","670","Saint Vincent and the Grenadines","2015","0.42","2015",null,"3.53","0.05",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","674","San Marino","2015","0.32","2015",null,"11.32","0.01",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","678","Sao Tome and Principe","2015","1.36","2015",null,"11.62","0.11",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","678","Sao Tome and Principe","2018","1.28","2018",null,"8.47","0.17",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","678","Sao Tome and Principe","2020","1.31","2020",null,"6.38","0.28",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","682","Saudi Arabia","2015","0.3","2015",null,"0.44","0.2",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","686","Senegal","2015","3.48","2015",null,"4.84","2.43",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","686","Senegal","2018","0.78","2018",null,"0.92","0.66",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","686","Senegal","2020","0.93","2020",null,"1.08","0.8",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","688","Serbia","2015","0.11","2015",null,"0.17","0.06",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","690","Seychelles","2015","0.15","2015",null,"0.44","0.04",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","690","Seychelles","2018","0.07","2018",null,"0.19","0.02",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","690","Seychelles","2020","0.09","2020",null,"0.23","0.03",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","694","Sierra Leone","2015","8.18","2015",null,"12.04","5.21",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","694","Sierra Leone","2018","2.22","2018",null,"2.58","1.9",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","694","Sierra Leone","2020","1.98","2020",null,"2.35","1.66",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","702","Singapore","2015","0.47","2015",null,"0.66","0.32",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","703","Slovakia","2015","0.56","2015",null,"0.79","0.37",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","704","Viet Nam","2015","1.2","2015",null,"1.62","0.84",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","705","Slovenia","2015","1.04","2015",null,"8.39","0.14",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","706","Somalia","2015","10.54","2015",null,"13.11","8.34",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","710","South Africa","2015","1.74","2015",null,"2.35","1.23",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","710","South Africa","2018","2.64","2018",null,"3.05","2.28",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","710","South Africa","2020","3.1","2020",null,"3.5","2.72",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","716","Zimbabwe","2015","4.38","2015",null,"6.33","2.92",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","716","Zimbabwe","2018","2.27","2018",null,"2.79","1.84",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","716","Zimbabwe","2020","2.74","2020",null,"3.27","2.26",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","722","Small island developing States (SIDS)","2018","0.8","2018",null,"1.15","0.65",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","722","Small island developing States (SIDS)","2020","0.54","2020",null,"0.86","0.42",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","724","Spain","2015","0.19","2015",null,"0.27","0.12",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","728","South Sudan","2015","21.13","2015",null,"26.21","16.74",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","728","South Sudan","2018","10.08","2018",null,"12.54","7.87",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","728","South Sudan","2020","13.03","2020",null,"15.14","11.29",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","729","Sudan","2015","2.86","2015",null,"4.02","1.95",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","740","Suriname","2015","0.36","2015",null,"3.84","0.03",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","747","Northern Africa and Western Asia","2015","0.84","2015",null,"1.22","0.57",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","747","Northern Africa and Western Asia","2018","0.48","2018",null,"0.57","0.4",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","747","Northern Africa and Western Asia","2020","0.47","2020",null,"0.6","0.37",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","748","Eswatini","2015","0.85","2015",null,"8.34","0.07",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","748","Eswatini","2018","4.69","2018",null,"5.54","3.89",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","748","Eswatini","2020","0.83","2020",null,"6.87","0.09",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","752","Sweden","2015","0.32","2015",null,"0.46","0.23",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","753","Eastern and South-Eastern Asia","2015","0.95","2015",null,"2.11","0.61",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","753","Eastern and South-Eastern Asia","2018","0.32","2018",null,"0.46","0.27",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","753","Eastern and South-Eastern Asia","2020","0.48","2020",null,"0.6","0.41",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","756","Switzerland","2015","0.17","2015",null,"0.31","0.09",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","760","Syrian Arab Republic","2015","0.37","2015",null,"0.57","0.24",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","762","Tajikistan","2015","0.71","2015",null,"1.17","0.43",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","764","Thailand","2015","0.17","2015",null,"0.26","0.1",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","768","Togo","2015","3.36","2015",null,"5.52","1.9",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","768","Togo","2018","3.04","2018",null,"3.8","2.38",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","768","Togo","2020","3.27","2020",null,"3.92","2.71",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","776","Tonga","2015","2.35","2015",null,"3.42","1.63",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","780","Trinidad and Tobago","2015","0.43","2015",null,"3.53","0.05",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","784","United Arab Emirates","2015","0.08","2015",null,"0.14","0.04",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","788","Tunisia","2015","0.76","2015",null,"1.08","0.51",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","792","Türkiye","2015","0.32","2015",null,"0.48","0.22",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","795","Turkmenistan","2015","0.23","2015",null,"1.76","0.02",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","798","Tuvalu","2015","0.7","2015",null,"1.56","0.23",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","800","Uganda","2015","3.16","2015",null,"4.29","2.28",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","800","Uganda","2018","1.52","2018",null,"1.84","1.25",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","800","Uganda","2020","0.96","2020",null,"1.12","0.81",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","804","Ukraine","2015","0.46","2015",null,"0.72","0.3",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","807","North Macedonia","2015","0.2","2015",null,"1.32","0.03",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","818","Egypt","2015","0.8","2015",null,"1.1","0.54",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","826","United Kingdom of Great Britain and Northern Ireland","2015","0.22","2015",null,"0.31","0.16",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","834","United Republic of Tanzania","2015","1.69","2015",null,"2.54","1.08",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","834","United Republic of Tanzania","2018","1.04","2018",null,"1.27","0.85",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","834","United Republic of Tanzania","2020","0.99","2020",null,"1.21","0.8",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","840","United States of America","2015","0.04","2015",null,"0.05","0.03",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","854","Burkina Faso","2015","4.29","2015",null,"5.77","3.03",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","854","Burkina Faso","2018","1.92","2018",null,"2.29","1.59",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","854","Burkina Faso","2020","1.66","2020",null,"1.93","1.39",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","858","Uruguay","2015","0.35","2015",null,"3.2","0.03",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","860","Uzbekistan","2015","0.6","2015",null,"0.93","0.38",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","862","Venezuela (Bolivarian Republic of)","2015","0.62","2015",null,"0.91","0.41",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","882","Samoa","2015","1.05","2015",null,"1.72","0.56",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","887","Yemen","2015","2.54","2015",null,"3.54","1.82",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","894","Zambia","2015","1.84","2015",null,"2.76","1.17",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","894","Zambia","2018","1.03","2018",null,"1.32","0.81",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]
["3","3.3","3.3.4","SH_HAP_HBSAG","Prevalence of hepatitis B surface antigen (HBsAg) (%)","894","Zambia","2020","1.32","2020",null,"1.64","1.03",null,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",null,null,"<5Y","E","G","PERCENT"]